Rumours about Chemist Warehouse, pharmacists winning on the national scene and more!
This week, the Australian Financial Review reported rumours that Chemist Warehouse was spending increasing face-to-face time meeting with fund managers and investment bankers, suggesting this may indicate “a potential run at the ASX-boards”.
AJP spoke with an industry analyst to get a clearer picture of what a listed Chemist Warehouse could look like – and how vulnerable our NZ neighbours are to the pharmacy group.
We reported on the star pharmacists recognised at the SHPA’s Medicine Management Conference 2017, including:
Dr Michael Barras – Winner, Medal of Merit
Dr Karen Whitfield – Australian Clinical Pharmacy Award
Amanda Horiniak – Resident of the Year
Sarah Marsh – Highly Commended Practitioner, Resident of the Year
And other coverage on the MM Conference included looking at:
- The role of the emergency department in opioid addiction;
- Pharmacist prescribing and their role in reducing harm;
- improving training and certification for pharmacy techs; and
- A roundup of interesting posters from the event.
We also saw Elise Apolloni from Capital Chemist Wanniassa score the National Telstra Young Business Women’s Award.
Johnson & Johnson Pacific confirmed that it is discontinuing its codeine-containing Codral formulation.
The same-sex marriage debate unwittingly put the kibosh on the annual Guild Parliamentary dinner, after the government cancelled a parliamentary sitting week, citing the need to pass same-sex marriage laws and deal with the citizenship fiasco.
With Amazon’s launch in Australia this week, shares in the US Rite Aid pharmacy group rose by more than 5% after one analyst wrote that Amazon should buy it to start selling drugs.
And a WA pharmacy finally got its PBS approval number after a groundswell of support from locals and politicians.
